Статті в журналах з теми "FDA problems"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "FDA problems".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
&NA;. "FDA: ADHD Meds May Increase Heart Problems." Nurse Practitioner 31, no. 4 (April 2006): 70. http://dx.doi.org/10.1097/00006205-200604000-00026.
Повний текст джерела&NA;. "FDA Takes Aim at Infusion Pump Problems." Journal of Clinical Engineering 35, no. 4 (October 2010): 174. http://dx.doi.org/10.1097/jce.0b013e3181fdb42b.
Повний текст джерелаGutman, Steven I., Janie G. Fuller, and Ethan D. Hausman. "Consumers Report Glucose Meter Problems to FDA." Diabetes Technology & Therapeutics 6, no. 6 (December 2004): 767–69. http://dx.doi.org/10.1089/dia.2004.6.767.
Повний текст джерелаKuehn, Bridget M. "FDA: Acetaminophen May Trigger Serious Skin Problems." JAMA 310, no. 8 (August 28, 2013): 785. http://dx.doi.org/10.1001/jama.2013.276938.
Повний текст джерелаHaffner, Marlene E., and John V. Kelsey. "Evaluation of Orphan Products by the U.S. Food and Drug Administration." International Journal of Technology Assessment in Health Care 8, no. 4 (1992): 647–57. http://dx.doi.org/10.1017/s0266462300002348.
Повний текст джерелаMook, Hailey. "FDA warns about dental problems associated with buprenorphine medications." Pharmacy Today 28, no. 4 (April 2022): 49. http://dx.doi.org/10.1016/j.ptdy.2022.03.021.
Повний текст джерелаGershon, Diane. "FDA panel sees problems with labelling of milk hormone." Nature 363, no. 6425 (May 1993): 107. http://dx.doi.org/10.1038/363107a0.
Повний текст джерелаMuni, Neal I., and Thomas P. Gross. "Problems with Drug-Eluting Coronary Stents — The FDA Perspective." New England Journal of Medicine 351, no. 16 (October 14, 2004): 1593–95. http://dx.doi.org/10.1056/nejmp048262.
Повний текст джерелаAult Barnett, Alicia. "FDA warns Pfizer on failure to report drug problems." Lancet 347, no. 9014 (June 1996): 1546. http://dx.doi.org/10.1016/s0140-6736(96)90694-7.
Повний текст джерелаHan, Ling-Na, Kai-Qiang Wang, Zi-Ning Ren, Xue Yang, Xiao Duan, Sasirekha Krishnan, Abinaya Jaisankar, et al. "One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics." RSC Advances 12, no. 43 (2022): 27963–69. http://dx.doi.org/10.1039/d2ra04436f.
Повний текст джерелаHalabi, Sam F. "The Codex Alimentarius Commission, Corporate Influence, and International Trade: A Perspective on FDA's Global Role." American Journal of Law & Medicine 41, no. 2-3 (May 2015): 406–21. http://dx.doi.org/10.1177/0098858815591525.
Повний текст джерелаLiu, Qinghua, Kai Ding, Bingsen Wu, and Quanmin Xie. "Frequency Diverse Array Target Localization Based on IPSO-BP." International Journal of Antennas and Propagation 2020 (August 27, 2020): 1–8. http://dx.doi.org/10.1155/2020/2501731.
Повний текст джерелаTanne, Janice Hopkins. "FDA works with US health insurers to identify drug problems." BMJ 336, no. 7650 (April 24, 2008): 913.2–913. http://dx.doi.org/10.1136/bmj.39559.404560.db.
Повний текст джерелаYoung, Donna. "ASHP, other groups, advise FDA about solving counterfeit drug problems." American Journal of Health-System Pharmacy 60, no. 23 (December 1, 2003): 2406. http://dx.doi.org/10.1093/ajhp/60.23.2406.
Повний текст джерелаLew, Helen, William D. Hadesty, Karen D. Bell, Francine M. DelVecchio, and Susan T. Chin. "fda import automation: Serious management and systems development problems persist." Information & Management 30, no. 3 (June 1996): 143–53. http://dx.doi.org/10.1016/0378-7206(95)00058-5.
Повний текст джерелаMitka, M. "FDA Advisory Decision Highlights Some Problems Inherent in Pragmatic Trials." JAMA: The Journal of the American Medical Association 306, no. 17 (November 1, 2011): 1851–52. http://dx.doi.org/10.1001/jama.2011.1570.
Повний текст джерелаSpringer, Janet A., and Foster D. Mcclure. "Statistical Sampling Approaches." Journal of AOAC INTERNATIONAL 71, no. 2 (March 1, 1988): 246–50. http://dx.doi.org/10.1093/jaoac/71.2.246.
Повний текст джерелаReed, Terrie L., and Diana Kaufman-Rivi. "FDA Adverse Event Problem Codes: Standardizing the Classification of Device and Patient Problems Associated with Medical Device Use." Biomedical Instrumentation & Technology 44, no. 3 (May 1, 2010): 248–56. http://dx.doi.org/10.2345/0899-8205-44.3.248.
Повний текст джерелаWang, Yintong, Jiandong Wang, Haiyan Chen, and Bo Sun. "Semi-Supervised Local Fisher Discriminant Analysis Based on Reconstruction Probability Class." International Journal of Pattern Recognition and Artificial Intelligence 29, no. 02 (February 27, 2015): 1550007. http://dx.doi.org/10.1142/s021800141550007x.
Повний текст джерелаKuehn, Bridget M. "FDA Turns to Electronic “Sentinel” to Flag Prescription Drug Safety Problems." JAMA 300, no. 2 (July 9, 2008): 156. http://dx.doi.org/10.1001/jama.300.2.156.
Повний текст джерелаXu, YanJie, ChunYang Wang, Jian Gong, YingJian Zhao, and ChangLin Zhou. "Mainlobe maintenance for FDA-MIMO radar." AIP Advances 12, no. 8 (August 1, 2022): 085305. http://dx.doi.org/10.1063/5.0099177.
Повний текст джерелаKlasmeier, Coleen, and Martin H. Redish. "Off-Label Prescription Advertising, the FDA and the First Amendment: A Study in the Values of Commercial Speech Protection." American Journal of Law & Medicine 37, no. 2-3 (June 2011): 315–57. http://dx.doi.org/10.1177/009885881103700206.
Повний текст джерелаBonet Olivencia, Samuel, and Farzan Sasangohar. "Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review." JMIR Formative Research 5, no. 3 (March 4, 2021): e14563. http://dx.doi.org/10.2196/14563.
Повний текст джерелаKarami, Hojat, Mahdi Valikhan Anaraki, Saeed Farzin, and Seyedali Mirjalili. "Flow Direction Algorithm (FDA): A Novel Optimization Approach for Solving Optimization Problems." Computers & Industrial Engineering 156 (June 2021): 107224. http://dx.doi.org/10.1016/j.cie.2021.107224.
Повний текст джерелаKnopf, Alison. "FDA warns about dental problems with buprenorphine medicines dissolved in the mouth." Brown University Child & Adolescent Psychopharmacology Update 24, no. 3 (February 10, 2022): 8. http://dx.doi.org/10.1002/cpu.30656.
Повний текст джерелаMarwick, Charles. "FDA Funding Problems Imperil Safety of Biological Products in the United States." JAMA 279, no. 12 (March 25, 1998): 899. http://dx.doi.org/10.1001/jama.279.12.899-jmn0325-2-1.
Повний текст джерелаE. Aliyeva, Sona. "Problems Regarding Comorbidity of Epilepsy with Depression in Children: A Literature Review." Psychology and Mental Health Care 6, no. 4 (June 4, 2022): 01–04. http://dx.doi.org/10.31579/2637-8892/169.
Повний текст джерелаGraham, Cynthia A., Petra M. Boynton, and Kate Gould. "Women’s Sexual Desire." European Psychologist 22, no. 1 (January 2017): 27–38. http://dx.doi.org/10.1027/1016-9040/a000282.
Повний текст джерелаMagrabi, Farah, Mei-Sing Ong, William Runciman, and Enrico Coiera. "Using FDA reports to inform a classification for health information technology safety problems." Journal of the American Medical Informatics Association 19, no. 1 (January 2012): 45–53. http://dx.doi.org/10.1136/amiajnl-2011-000369.
Повний текст джерелаTIMBO, BABGALEH, KATHLEEN M. KOEHLER, CECILIA WOLYNIAK, and KARL C. KLONTZ. "Sulfites—A Food and Drug Administration Review of Recalls and Reported Adverse Events." Journal of Food Protection 67, no. 8 (August 1, 2004): 1806–11. http://dx.doi.org/10.4315/0362-028x-67.8.1806.
Повний текст джерелаEvans, Barbara J. "The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act." American Journal of Law & Medicine 38, no. 4 (December 2012): 577–606. http://dx.doi.org/10.1177/009885881203800401.
Повний текст джерелаGECAN, JOHN S., and STANLEY M. CICHOWICZ. "Toxic Mushroom Contamination of Wild Mushrooms in Commercial Distribution." Journal of Food Protection 56, no. 8 (August 1, 1993): 730–34. http://dx.doi.org/10.4315/0362-028x-56.8.730.
Повний текст джерелаBujnak, Alyssa, Carly A. Crowder, and Michael L. Krychman. "Energy-Based Devices for Functional Vaginal Problems: Issues and Answers." Current Sexual Health Reports 13, no. 1 (February 26, 2021): 1–13. http://dx.doi.org/10.1007/s11930-021-00302-x.
Повний текст джерелаWang, Yuzhuo, Shengqi Zhu, Lan Lan, Ximin Li, Zhixin Liu, and Zhixia Wu. "Range-Ambiguous Clutter Suppression via FDA MIMO Planar Array Radar with Compressed Sensing." Remote Sensing 14, no. 8 (April 15, 2022): 1926. http://dx.doi.org/10.3390/rs14081926.
Повний текст джерелаBayless, William C. "LATE PUBLICATION OF PRODUCT RECALLS BY FDA CAN CAUSE PROBLEMS FOR MANUFACTURERS AND HOSPITALS." Biomedical Safety & Standards 15, no. 12 (June 1985): 94. http://dx.doi.org/10.1097/00149078-198506150-00010.
Повний текст джерелаMarwick, Charles. "Nontherapeutic Problems of Generic Drugs Lead to Call for FDA, Legislative Diagnosis and Cure." JAMA: The Journal of the American Medical Association 262, no. 12 (September 22, 1989): 1566. http://dx.doi.org/10.1001/jama.1989.03430120016004.
Повний текст джерелаMarwick, C. "Nontherapeutic problems of generic drugs lead to call for FDA, legislative diagnosis and cure." JAMA: The Journal of the American Medical Association 262, no. 12 (September 22, 1989): 1566–67. http://dx.doi.org/10.1001/jama.262.12.1566.
Повний текст джерелаDempsey, James J., and Mark Ross. "Evaluation of Hardwire Personal Assistive Listening Devices." American Journal of Audiology 3, no. 2 (July 1994): 71–77. http://dx.doi.org/10.1044/1059-0889.0301.71.
Повний текст джерелаAbramson, Norman, Alan Meisel, and Peter Safar. "Ethical and Legal Problems in Resuscitation Research." Prehospital and Disaster Medicine 1, S1 (1985): 59–60. http://dx.doi.org/10.1017/s1049023x00043788.
Повний текст джерелаThomas, W. John. "The Vioxx Story: Would it Have Ended Differently in the European Union?" American Journal of Law & Medicine 32, no. 2-3 (June 2006): 365–80. http://dx.doi.org/10.1177/009885880603200210.
Повний текст джерелаHino, Hideitsu, and Noboru Murata. "A Conditional Entropy Minimization Criterion for Dimensionality Reduction and Multiple Kernel Learning." Neural Computation 22, no. 11 (November 2010): 2887–923. http://dx.doi.org/10.1162/neco_a_00027.
Повний текст джерелаLu, Kevin, and Patricia Slattum. "USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS." Innovation in Aging 6, Supplement_1 (November 1, 2022): 193. http://dx.doi.org/10.1093/geroni/igac059.770.
Повний текст джерелаShuster, Joel. "ADRs Causing Hospital Admissions; A Reader's Tale of Serotonin Syndrome; Adverse Effects of Laxatives; Oxcarbazepine-Induced SIADH; Two Problems with Fluoroquinolones." Hospital Pharmacy 37, no. 11 (November 2002): 1143–46. http://dx.doi.org/10.1177/001857870203701109.
Повний текст джерелаSun, Chunlei, Xi Rong, Yongqin Cai, Song Qiu, and Maryam Farzaneh. "Mini review: The FDA‐approved prescription drugs that induce ovulation in women with ovulatory problems." Drug Development Research 81, no. 7 (May 19, 2020): 815–22. http://dx.doi.org/10.1002/ddr.21687.
Повний текст джерелаVENUGOPAL, RAJESH, LINDA TOLLEFSON, FREDERICK N. HYMAN, BAB TIMBO, RONALD E. JOYCE, and KARL C. KLONTZ. "Recalls of Foods and Cosmetics by the U.S. Food and Drug Administration." Journal of Food Protection 59, no. 8 (August 1, 1996): 876–80. http://dx.doi.org/10.4315/0362-028x-59.8.876.
Повний текст джерелаWallin, Richard F. "Current Problems in Devices Evaluation: Some Solutions." Journal of the American College of Toxicology 7, no. 4 (July 1988): 491–97. http://dx.doi.org/10.3109/10915818809019522.
Повний текст джерелаDreyfus, J. F., D. Cremniter, and J. D. Guelfi. "Reflections on FDA and WHO recommendations concerning clinical trials." Psychiatry and Psychobiology 4, no. 2 (1989): 117–22. http://dx.doi.org/10.1017/s0767399x00002960.
Повний текст джерелаNikoobin, A., and M. Moradi. "Indirect solution of optimal control problems with state variable inequality constraints: finite difference approximation." Robotica 35, no. 1 (July 2, 2015): 50–72. http://dx.doi.org/10.1017/s0263574715000521.
Повний текст джерелаAzevedo, Leonardo. "Model reduction in geostatistical seismic inversion with functional data analysis." GEOPHYSICS 87, no. 1 (November 10, 2021): M1—M11. http://dx.doi.org/10.1190/geo2021-0096.1.
Повний текст джерелаMeléndez, Rafael, Ramón Giraldo, and Víctor Leiva. "Sign, Wilcoxon and Mann-Whitney Tests for Functional Data: An Approach Based on Random Projections." Mathematics 9, no. 1 (December 28, 2020): 44. http://dx.doi.org/10.3390/math9010044.
Повний текст джерела